Pathfinder Cell Therapy Quick Ratio (PFND) starting from the third quarter 2015 to third quarter 2014, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Pathfinder Cell Therapy, Inc.  (PFND)

Pathfinder Cell Therapy's Quick Ratio

PFND's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2015, Quick Ratio fell to 0 a new company low.

Within Medical Equipment & Supplies industry 191 other companies have achieved higher Quick Ratio than Pathfinder Cell Therapy in third quarter 2015. While Quick Ratio total ranking has improved so far during the Q3 2015 to 5144, from total ranking in the second quarter 2015 at 6043.

Explain Quick Ratio?
How much Cash & cash equivalents PFND´s has?
What are PFND´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PFND Quick Ratio (Sep 30 2015)
Q3		 (Jun 30 2015)
Q2		 (Mar 31 2015)
Q1		 (Dec 31 2014)
Q4		 (Sep 30 2014)
Q3
Y / Y Current Liabilities Change 18.34 % 19.32 % 21.79 % 28.54 % 702.24 %
Y / Y Cash & cash equivalent Change -82.61 % - -68.18 % -40.91 % -54.9 %
Quick Ratio MRQ 0 - 0 0 0
PFND's Total Ranking # 5144 # 6043 # 5012 # 5004 # 5010
Seq. Current Liabilities Change 4.3 % 2.93 % 4.23 % 5.75 % 5.17 %
Seq. Cash & cash equivalent Change - - -19.23 % 13.04 % 9.52 %



Quick Ratio third quarter 2015 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 192
Healthcare Sector # 788
Overall Market # 5144


Quick Ratio Statistics
High Average Low
0.58 0.08 0
(Sep 30 2011)   (Sep 30 2015)




Financial Statements
Pathfinder Cell Therapy's Current Liabilities $ 7 Millions Visit PFND's Balance sheet
Pathfinder Cell Therapy's Cash & cash equivalent $ 0 Millions Visit PFND's Balance sheet
Source of PFND's Sales Visit PFND's Sales by Geography


Cumulative Pathfinder Cell Therapy's Quick Ratio

PFND's Quick Ratio for the trailling 12 Months

PFND Quick Ratio

 (Sep 30 2015)
12 Months		 (Jun 30 2015)
12 Months		 (Mar 31 2015)
12 Months		 (Dec 31 2014)
12 Months		 (Sep 30 2014)
12 Months
Y / Y Current Liabilities TTM Growth 21.72 % 53.19 % 62.43 % 74.73 % 89.91 %
Y / Y Cash & cash equivalent TTM Growth -66.88 % -61.54 % -60.26 % -18.07 % 17.56 %
Quick Ratio TTM 0 0 0 0.01 0.01
Total Ranking TTM # 3826 # 3995 # 3858 # 3827 # 3826
Seq. Current Liabilities TTM Growth 4.27 % 4.47 % 5.04 % 6.38 % 31.23 %
Seq. Cash & cash equivalent TTM Growth -27.14 % -23.08 % -33.09 % -11.69 % -15.38 %

Quick ratio ranking by company, industry and sector >> Back to PFND Financial Strength Comparisons >> Go to Compare PFND Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the unchanged in Current Liabilities in the Q3 2015 to $6.77 millions, cumulative Quick Ratio